Applied Photophysics (APP) and Fluorescence Innovations (FI) have entered into a joint venture agreement to develop and produce protein stability systems for leading researchers and industries around the globe.
The two firms said they will be equal partners in the new initiative. The joint venture will be autonomous and independent, with APP and FI continuing to compete in all other business areas, the companies said. They anticipate that joining forces on protein stability systems will lower development costs and bring forward a cutting-edge technology centered around a chemical melt protein stability system.
“With the development of biopharmaceuticals, comes the need for discovery tools and new analysis tools to ensure the safety of product and ability to get the products to the patient in a timely, safe and user-friendly manner,” said Tim Flanagan, CEO Protein Stable said in a statement.
Both companies aim to offer their specific expertise with FI handling the development of the technology and APP offering streamlined sales and manufacturing support to produce the system. Both companies have significantly played a vital role in the success of the newly-founded Protein Stable.
